Big Pharma has long had to contend with rigorous electronic reporting standards, designed to protect patients. Now, it’s the turn of medical device manufacturers, which have so far escaped the same transparency measures. So what does best practice data management and reporting look like? Amplexor’s Elvis Paćelat distils some tips from the pharmaceutical industry’s experiences.

Elvis Paćelat is Vice President Compliance Management at Amplexor Life Sciences. Elvis is a business and technology executive with more than two decades of international experience in the Life Sciences market. With detailed technical understanding and expertise in compliance and regulatory content management solutions for Life Sciences, Elvis is a specialist in business impact analysis. As Amplexor’s VP Compliance Management, he is responsible for driving the corporate strategy and market success of the Amplexor Life Sciences’ suite business. Elvis is committed to delivering benefit for clients, partners and shareholders, whilst supporting client-centric strategies and spearheading groundbreaking innovations.